MarketPulse

SUBLOCADE

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Indivior Pharmaceuticals, Inc.

Indivior's Buprenorphine Data Shows Lowest Overdose Rates Among OUD Treatments

Indivior reports SUBLOCADE injectable buprenorphine shows lowest overdose rates among OUD treatments, with data supporting remission as meaningful outcome.
INDVbuprenorphineSUBLOCADE
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Indivior Signals Q1 2026 Results as SUBLOCADE Gains Ground in Correctional Care

$INDV to report Q1 2026 earnings April 30, highlighting SUBLOCADE's cost-reduction potential in correctional facilities amid opioid crisis.
INDVfinancial resultscost reduction
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Indivior Taps Convertible Debt Market for $400M Refinancing Push

Indivior plans $400M convertible notes offering to refinance debt and fund buybacks, reflecting broader pharmaceutical sector refinancing trends.
INDVcapital structureshare repurchase